RNA Pseudogene 287: Potential Drug Target and Biomarker (G106480921)

Target Name: RN7SKP287

NCBI ID: G106480921

RN7SKP287

Other Name(s): RN7SK pseudogene 287 | RNA, 7SK small nuclear pseudogene 287

RNA Pseudogene 287: Potential Drug Target and Biomarker

The RN7SK pseudogene 287 is a non-coding RNA molecule that has been identified in various human tissues and has been annotated as a potential drug target or biomarker. The RNA molecule is characterized by its highly conserved sequence and its expression pattern, which has led to its interest in a variety of biological processes.

The RN7SK pseudogene 287 is a member of the RPGR family, which includes several non-coding RNAs that are involved in the regulation of gene expression. These RNAs have been shown to play important roles in various biological processes, including cell growth, differentiation, and development.

Expression and Localization

RNA expression is a critical process that occurs in various biological organisms, and the regulation of gene expression is a crucial aspect of this process. The RN7SK pseudogene 287 is expressed in various human tissues, including brain, heart, liver, and muscle. Its expression pattern varies depending on the tissue and developmental stage of the organism.

The RN7SK pseudogene 287 is primarily expressed in the brain, where it is expressed at relatively high levels. The expression of the RNA molecule is also influenced by various factors, including the amount of RNA polymerase II (RNA polymerase II) available in the cell, the levels of intracellular signaling molecules, and the presence of various post-transcriptional modifications.

Drug Target Potential

The RN7SK pseudogene 287 has been identified as a potential drug target due to its involvement in various signaling pathways. The RNA molecule has been shown to play important roles in the regulation of cell growth, differentiation, and survival. Its expression is also influenced by various signaling pathways, including the TGF-β pathway, which is involved in cell growth and development.

The TGF-β pathway is a well-established pathway that is involved in the regulation of cell growth and differentiation. This pathway is activated by various signaling molecules, including TGF-β1, which is a potent growth-promoting protein. The RNA molecule has been shown to play a role in the regulation of TGF-β1 signaling, as well as the regulation of cell survival and differentiation.

In addition to its involvement in the TGF-β pathway, the RN7SK pseudogene 287 has also been shown to play a role in the regulation of cell adhesion. Adhesion is a critical process that is involved in the regulation of various biological processes, including tissue repair and regeneration.

Biomarker Potential

The RN7SK pseudogene 287 has also been identified as a potential biomarker for a variety of diseases, including cancer. Its expression pattern is influenced by various factors, including the level of RNA polymerase II available in the cell, which is involved in the regulation of gene expression.

The RN7SK pseudogene 287 has also been shown to play a role in the regulation of cell cycle progression. The cell cycle is a critical process that is involved in the regulation of various biological processes, including cell growth and differentiation. The RNA molecule has been shown to play a role in the regulation of cell cycle progression, as well as the regulation of cell growth and differentiation.

Conclusion

The RN7SK pseudogene 287 is a non-coding RNA molecule that has been identified in various human tissues and has been annotated as a potential drug target or biomarker. Its expression pattern is influenced by various factors, including the level of RNA polymerase II available in the cell and the levels of intracellular signaling molecules. The RNA molecule has also been shown to play important roles in the regulation of cell growth, differentiation, and survival, as well as the regulation of cell adhesion and the cell cycle. Further research is needed to fully understand the role of the RN7SK pseudogene 287 in various biological processes.

Protein Name: RN7SK Pseudogene 287

The "RN7SKP287 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SKP287 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets